Page last updated: 2024-11-03

procainamide and Neuromuscular Diseases

procainamide has been researched along with Neuromuscular Diseases in 2 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agius, MA1
Zhu, S1
Fairclough, RH1
Oh, SJ1
Elmore, RS1
Sarala, PK1
Kuba, T1

Other Studies

2 other studies available for procainamide and Neuromuscular Diseases

ArticleYear
Antirapsyn antibodies in chronic procainamide-associated myopathy (CPAM).
    Annals of the New York Academy of Sciences, 1998, May-13, Volume: 841

    Topics: Aged; Aged, 80 and over; Animals; Autoantibodies; Chronic Disease; Electric Organ; Enzyme-Linked Imm

1998
Procainamide-induced myasthenia-like syndrome.
    Muscle & nerve, 1986, Volume: 9, Issue:7

    Topics: Humans; Middle Aged; Neuromuscular Diseases; Procainamide

1986